Stoke Therapeutics, Inc.
STOK- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001623526
In the last 90 days, Stoke Therapeutics, Inc. insiders filed 0 open-market purchases and 6 sales; 197 institutions reported holding it in 13F filings for Q2 2026, worth $2.49B in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Stoke Therapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 107
- +2 vs. Q3 2022
- Shares held
- 40.3M
- −1.99M (−4.7%) vs. Q3 2022
- Total value
- $371.8M
- −$172.5M (−31.7%) vs. Q3 2022
- New holders
- 14
- 44 more added
- Sold out
- 12
- 33 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting STOK on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 197 | $2.49B |
| Q1 2026 | 198 | $2.31B |
| Q4 2025 | 183 | $2.13B |
| Q3 2025 | 151 | $1.57B |
| Q2 2025 | 134 | $744.0M |
| Q1 2025 | 126 | $421.6M |
| Q4 2024 | 130 | $640.4M |
| Q3 2024 | 118 | $715.5M |
| Q2 2024 | 115 | $828.5M |
| Q1 2024 | 103 | $731.7M |
| Q4 2023 | 81 | $236.9M |
| Q3 2023 | 97 | $173.1M |
| Q2 2023 | 100 | $494.8M |
| Q1 2023 | 97 | $371.8M |
| Q4 2022 | 107 | $371.8M |
| Q3 2022 | 105 | $544.4M |
| Q2 2022 | 92 | $569.4M |
| Q1 2022 | 99 | $870.6M |
| Q4 2021 | 94 | $849.6M |
| Q3 2021 | 90 | $492.4M |
| Q2 2021 | 97 | $680.3M |
| Q1 2021 | 106 | $1.49B |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Stoke Therapeutics, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Baker Bros. Advisors LP | 1,108,913 | $10.2M | 0.06% | +739,586+200.3% | Added |
| Vanguard Group Inc | 1,602,045 | $14.8M | 0.00% | −445,859−21.8% | Reduced |
| BlackRock Inc. | 1,830,647 | $16.9M | 0.00% | +123,444+7.2% | Added |
| Morgan Stanley | 2,453,686 | $22.6M | 0.00% | −158,356−6.1% | Reduced |
| FMR LLC | 3,034,649 | $28.0M | 0.00% | −147,854−4.6% | Reduced |
| RTW Investments, LP | 3,870,981 | $35.7M | 0.73% | +219,158+6.0% | Added |
| Skorpios Trust | 14,443,681 | $133.3M | 42.40% | 00.0% | Unchanged |
| Avidity Partners Management LP | 0 | $0 | 0.00% | −891,100−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −62,939−100.0% | Sold out |
| Ensign Peak Advisors, Inc | 0 | $0 | 0.00% | −43,112−100.0% | Sold out |
| Teachers Retirement System of the State of Kentucky | 0 | $0 | 0.00% | −42,598−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −20,617−100.0% | Sold out |
| DekaBank Deutsche Girozentrale | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −15,702−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −11,135−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −7,933−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −1,636−100.0% | Sold out |
| First Manhattan Co | 0 | $0 | 0.00% | −150−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −21−100.0% | Sold out |